OPNT - Opiant Pharmaceuticals EPS misses by $0.21 misses on revenue May, 12 2020 04:07 PM Opiant Pharmaceuticals Inc. Opiant Pharmaceuticals (NASDAQ:OPNT): Q1 GAAP EPS of -$0.40 misses by $0.21.Revenue of $4.28M (-21.3% Y/Y) misses by $0.57M.Press ReleaseMore news on: Opiant Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,